FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

ICH Patient Preference Guidelines Out for Comment

FDA publishes for public comment an International Council for Harmonization draft guideline on patient preference studies involving drug characteristi...

Animal Drugs

Sangamo Begins Rolling BLA for Fabry Gene Therapy

Sangamo Therapeutics begins a rolling BLA submission seeking accelerated approval of its experimental Fabry disease gene therapy, following results fr...

latest-news-card-1
Human Drugs

Bayers Asundexian Cuts Recurrent Stroke Risk in Phase 3

Bayer reports that its investigational oral anticoagulant asundexian reduced the risk of recurrent ischemic stroke by 26% in patients who had recently...

Human Drugs

Industry Explains PDUFA 8 Facility Lifecycle Counterproposal

A PDUFA 8 negotiating subgroup reviews industrys counterproposal to FDAs facility lifecycle proposal.

latest-news-card-1
Human Drugs

Telehealth Firm Undercuts Novo GLP-1 Pill Price: Reuters

Reuters reports exclusively that the telehealth firm Hims and Hers Health is selling GLP-1 pills for $100 less per month than the branded version offe...

latest-news-card-1
Medical Devices

J&Js Cerenovus Recalls Neurovascular Coil Devices

Johnson & Johnson MedTech recalls multiple versions of its Cerepak Detachable Coil System, which are used to treat intracranial aneurysms and other ne...

latest-news-card-1
Human Drugs

FDA Updates Safety Labels for Chemo Drugs

FDA updates the safety labeling for the widely used chemotherapy drugs capecitabine (Genentechs Xeloda) and fluorouracil (multiple manufacturers) to s...

latest-news-card-1
Medical Devices

Software Assurance Guidance Supplement

FDA publishes a guidance with recommendations on computer software assurance for computers and automated data processing systems used as part of medic...

latest-news-card-1
Human Drugs

Funding Bill Reinstates FDA Pediatric Drug Voucher Program

President Trump signs a government spending bill that officially reinstates FDAs Rare Pediatric Disease Priority Review Voucher program.

Medical Devices

QS Violations at Flextronics America

FDA warns Austin, TX-based Flextronics America about Quality Systems violations in its manufacturing of a continuous glucose meter.